COMMUNIQUÉS West-GlobeNewswire

Inovio Pharmaceuticals to Participate In Upcoming Investment Conferences
09/11/2017
PLYMOUTH MEETING, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced that the Company will participate in the following upcoming investment conferences: Stifel 2017 [...]
Golden Leaf Holdings Wins Big at Third Annual Oregon DOPE Cup
09/11/2017
PORTLAND, Ore., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Golden Leaf Holdings (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, celebrated last week as [...]
VBL Therapeutics to Present at the 22nd Annual Scientific Meeting of the Society for Neuro-Oncology (SNO) on November 18
09/11/2017
TEL AVIV, Israel, Nov. 09, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]
Madrigal Pharmaceuticals Reports 2017 Third Quarter Financial Results
09/11/2017
CONSHOHOCKEN, Penn., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL ) today announced its third quarter 2017 financial results and several clinical accomplishments that occurred during [...]
Repligen Reports Third Quarter 2017 Financial Results
09/11/2017
Record quarterly revenue of $36.6 million represents 48% year-over-year growth Year-to-date revenue of $99.6 million represents 26% year-over-year growth Spectrum contributes revenue of $7.6 million in first two months [...]
Xtant Medical Postpones Release of Third Quarter 2017 Financial Results
09/11/2017
BELGRADE, Mont., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, announced that it has postponed [...]
Avenue Therapeutics Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights
09/11/2017
NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI ) (“Avenue”), a Fortress Biotech (NASDAQ: FBIO ) Company, today announced financial results and recent corporate highlights for the [...]
Merus to Present at the Jefferies London Healthcare Conference
09/11/2017
UTRECHT, The Netherlands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ: MRUS ), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that Ton [...]
Idera Pharmaceuticals Presents Positive Translational and Clinical Data Update from Ongoing IMO-2125 Development Program at the 2017 Society for Immunotherapy of Cancer Annual Meeting (SITC)
09/11/2017
- Available Translational Data Continue to Demonstrate Correlation between Proliferation and Clonal Expansion of T-Cells to Clinical Responses - - An additional 5th Unconfirmed RECIST v1.1 Response Observed in 10th [...]
Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Fourth Quarter Cash Dividend, Sets Fiscal 2018 Cash Dividend Rate, and Reaffirms Fiscal 2018 Guidance
09/11/2017
GENERAL HIGHLIGHTS CINCINNATI, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO ) today: reported fourth quarter and full-year fiscal 2017 net revenues of $49.7 million and $200.8 million, [...]
Interpace Diagnostics to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results and Business Progress on Monday November 13, 2017
09/11/2017
PARSIPPANY, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically useful molecular [...]
Cancer Genetics Reports Record Third Quarter 2017 Revenue and 134% Increase in Contracted Bookings from Major Biotech and Pharmaceutical Companies
09/11/2017
Actively Working with 9 of Top 10 Biopharma Companies Globally Revenue Increased 19% to $8.0 Million, Gross Margin Improved to 43% Conference call at 8:30 a.m. EST, Thursday, November 9, 2017 RUTHERFORD, N.J., Nov. 09, [...]
Alliqua BioMedical, Inc. Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year 2017 Financial Outlook
09/11/2017
YARDLEY, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA ) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today [...]
Alliqua BioMedical, Inc. Engages Cowen to Assist in Evaluating Potential Strategic Alternatives
09/11/2017
YARDLEY, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA ) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today [...]
Summit Highlights Utrophin Modulation as a Potential Universal Treatment Option in DMD at Action Duchenne
09/11/2017
Summit Therapeutics plc ("Summit" or the "Company") SUMMIT HIGHLIGHTS UTROPHIN MODULATION AS A POTENTIAL UNIVERSAL TREATMENT OPTION IN DMD AT 15th ACTION DUCHENNE INTERNATIONAL CONFERENCE New Preclinical Data Show [...]
Sanofi, Principia agree to develop multiple sclerosis drug candidate
09/11/2017
Sanofi, Principia agree to develop multiple sclerosis drug candidate Clinical-stage oral drug candidate (PRN2246) with the potential to treat multiple sclerosis Principia to receive $40 million upfront payment, future [...]
Accord entre Sanofi et Principia pour le développement d'un candidat-médicament contre la sclérose en plaques
09/11/2017
Accord entre Sanofi et Principia pour le développement d'un candidat-médicament contre la sclérose en plaques L'accord porte sur un candidat-médicament par voie orale au stade du développement clinique (PRN2246) dans le [...]
2017 HomeCare Elite Recognizes Top Amedisys Care Centers Nationwide
09/11/2017
BATON ROUGE, La., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Amedisys (NASDAQ: AMED ), a leading healthcare at home company, today announced that 48 percent of its home health care centers across the country have been named to [...]
Natus to Present at 29th Annual Piper Jaffray Healthcare Conference
09/11/2017
PLEASANTON, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) today announced that Jonathan Kennedy, Executive Vice President and Chief Financial Officer, will present at the 29 th [...]

Pages